IN2013MU03491A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03491A
IN2013MU03491A IN3491MU2013A IN2013MU03491A IN 2013MU03491 A IN2013MU03491 A IN 2013MU03491A IN 3491MU2013 A IN3491MU2013 A IN 3491MU2013A IN 2013MU03491 A IN2013MU03491 A IN 2013MU03491A
Authority
IN
India
Prior art keywords
treosulfan
relates
present
improved
methylsulfonyloxybutyl
Prior art date
Application number
Other languages
English (en)
Inventor
Sougata Pramanick
Vikram Shamrao Gharge
Krishna Barsu Kinage
Rushil Vidhyutbhai Shah
Mukund Keshav Gurjar
Samit Satish Mehta
Original Assignee
Emcure Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emcure Pharmaceuticals Ltd filed Critical Emcure Pharmaceuticals Ltd
Priority to PCT/IN2014/000692 priority Critical patent/WO2015107534A1/fr
Priority to IN3491MU2013 priority patent/IN2013MU03491A/en
Publication of IN2013MU03491A publication Critical patent/IN2013MU03491A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN3491MU2013 2013-11-04 2014-10-31 IN2013MU03491A (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IN2014/000692 WO2015107534A1 (fr) 2013-11-04 2014-10-31 Formulation lyophilisée de tréosulfan
IN3491MU2013 IN2013MU03491A (fr) 2013-11-04 2014-10-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3491MU2013 IN2013MU03491A (fr) 2013-11-04 2014-10-31

Publications (1)

Publication Number Publication Date
IN2013MU03491A true IN2013MU03491A (fr) 2015-07-31

Family

ID=53039936

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3491MU2013 IN2013MU03491A (fr) 2013-11-04 2014-10-31

Country Status (2)

Country Link
IN (1) IN2013MU03491A (fr)
WO (1) WO2015107534A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE064508T2 (hu) * 2018-09-26 2024-03-28 Medac Ges Fuer Klinische Spezialpraeparate Mbh Treoszulfán liofilizát
WO2020064816A1 (fr) 2018-09-26 2020-04-02 Medac Gesellschaft für klinische Spezialpräparate mbH Solution comprenant du tréosulfan
EP3856346A1 (fr) 2018-09-26 2021-08-04 medac Gesellschaft für klinische Spezialpräparate mbH Forme cristalline de tréosulfan

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155702A (en) 1960-02-22 1964-11-03 Lphivens Kemiske Fabrik Ved A Stereoisomers and the racemate of butane-1, 2, 3, 4-tetrol-1, 4-di
ES2337134T3 (es) * 2002-03-12 2010-04-21 Bristol-Myers Squibb Company Derivados de c3-ciano-epotilona.
WO2008135232A1 (fr) * 2007-05-02 2008-11-13 Riccardo Cortese Utilisation et compositions de dérivés de purine pour le traitement de troubles prolifératifs
DE102009022046A1 (de) * 2009-05-16 2010-11-18 Evoria Gmbh Entfärbte Extrakte der Pflanze Pandanus conoideus

Also Published As

Publication number Publication date
WO2015107534A1 (fr) 2015-07-23

Similar Documents

Publication Publication Date Title
PH12020550552A1 (en) Inhibitors of hepatitis c virus
ZA201507627B (en) P2x7 modulators
NZ729443A (en) Heterocyclic modulators of lipid synthesis
NZ711982A (en) Cytotoxic and anti-mitotic compounds, and methods of using the same
EA201400833A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EP2982367A4 (fr) Composition pharmaceutique pour administration parentérale, contenant du donepezil
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
HRP20181333T1 (hr) Novi derivati indola i pirola, metoda za njihovu proizvodnju i farmaceutski pripravci koji ih sadržavaju
EA201600124A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
GEP201706760B (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
UA115357C2 (uk) Похідні піридин-4-ілу
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
EP3003360A4 (fr) Compositions pharmaceutiques de pancréatine de haute puissance
EA201500821A1 (ru) Производные 2-замещенных-6-биарилметиламино-9-циклопентил-9н-пуринов, их использование в качестве лекарственных средств и фармацевтических составов
EA201600394A1 (ru) Трициклические соединения пиперидина
EA201600122A1 (ru) Новые изоиндолиновые или изохинолиновые соединения, способ их получения и фармацевтические композиции, содержащие их
IN2013MU03491A (fr)
WO2012061012A3 (fr) Analogues 4-amino-2h-pyran-2-one en tant qu'agents anticancéreux
HK1225381A1 (zh) 具抗記憶錯誤效果的乙酰膽碱酯酶抑制劑和5-羥色胺受體4(5ht4)激動劑的化合物，其製備方法及其含有的藥物組合物
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
IN2013CH04314A (fr)
UA114396C2 (uk) Фармацевтична композиція з антиішемічною та антигіпертензивною дією
IN2013MU03656A (fr)